Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 5926 - 5950 of 11085 in total
Experimental
Matched Name: … 1,2-diacyl-sn-glycero-3-phosphoinositol …
Matched Iupac: … (2R)-1-(hexadecanoyloxy)-3-{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl phosphonato]oxy}propan ... -2-yl (9E)-octadec-9-enoate …
Experimental
Matched Name: … 1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea …
Matched Iupac: … 3-(4-carbamimidoylphenyl)-1-(4-phenoxyphenyl)urea …
Experimental
Matched Synonyms: … 3-indoleacetamide ... Indole-3-acetamide ... 1H-indole-3-acetamide …
Matched Iupac: … 2-(1H-indol-3-yl)acetamide …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Lintuzumab actinium Ac-225 is under investigation in clinical trial NCT00672165 (Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies).
Investigational
Investigational
Matched Synonyms: … LEDGF(1-326) ... Lens epithelial derived growth factor (1-326) …
Investigational
Investigational
Matched Synonyms: … 4-quinolinamine, 7-chloro-n-(3-(4-((di-2-pyridinylmethyl)amino)-1-piperidinyl)propyl)- …
Matched Iupac: … N-[3-(4-{[bis(pyridin-2-yl)methyl]amino}piperidin-1-yl)propyl]-7-chloroquinolin-4-amine …
Experimental
Matched Name: … D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate …
Matched Iupac: … {[(2R,3S,4S,5R)-3,4-dihydroxy-5-(phosphonomethyl)oxolan-2-yl]methoxy}phosphonic acid …
A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES. [PubChem]
Experimental
Matched Description: … A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Experimental
Illicit
Experimental
Matched Name: … 6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one …
Matched Iupac: … 6-amino-2-{[(naphthalen-1-yl)methyl]amino}-3H,7H,8H-imidazo[4,5-g]quinazolin-8-one …
Experimental
Matched Name: … (2E)-3-(3,4-DIHYDROXYPHENYL)-2-IMINOPROPANOIC ACID …
Matched Iupac: … 3-(3,4-dihydroxyphenyl)-2-iminopropanoic acid …
Experimental
Matched Name: … (2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide …
Matched Iupac: … (2Z)-2-cyano-N-{3'-ethoxy-[1,1'-biphenyl]-4-yl}-3-hydroxybut-2-enamide …
Experimental
Matched Name: … (1r,4s)-2-Azabornane …
Matched Iupac: … (1R,4S)-1,7,7-trimethyl-2-azabicyclo[2.2.1]heptane …
Experimental
Matched Name: … 3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL …
Matched Iupac: … 3-({4-amino-1-tert-butyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl}methyl)phenol …
A 20-carbon-chain fatty acid, unsaturated at positions 8, 11, and 14. It differs from arachidonic acid, 5,8,11,14-eicosatetraenoic acid, only at position 5.
Investigational
Nutraceutical
Matched Synonyms: … 20:3, n-6,9,12 all-cis ... C20:3, n-6,9,12 all-cis …
Matched Description: … It differs from arachidonic acid, 5,8,11,14-eicosatetraenoic acid, only at position 5. …
Bifeprunox is a novel atypical antipsychotic agent which, along with SLV313, aripiprazole and SSR-181507 combines minimal D2 receptor agonism with 5-HT receptor agonism.
Investigational
Matched Iupac: … 7-[4-({[1,1'-biphenyl]-3-yl}methyl)piperazin-1-yl]-2,3-dihydro-1,3-benzoxazol-2-one …
Matched Description: … agent which, along with SLV313, [aripiprazole] and SSR-181507 combines minimal D2 receptor agonism with 5- …
Matched Salts cas: … 350992-13-1
Matched Categories: … Heterocyclic Compounds, 1-Ring ... Heterocyclic Compounds, 2-Ring …
Experimental
Matched Iupac: … (2R,3R,4S,5R)-4-{[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}oxane-2,3,5-triol …
Snubh-nm-333 F-18 is under investigation in clinical trial NCT02149017 (Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F)).
Investigational
Matched Iupac: … 4-[6-(¹⁸F)fluoro-1,3-benzothiazol-2-yl]-N-methylaniline …
Matched Description: … Snubh-nm-333 F-18 is under investigation in clinical trial NCT02149017 (Phase 1 and Phase 2 Clinical …
AAV1-FS344 is an investigational gene therapy developed by Milo Biotechnology to deliver follistatin, a potent myostatin inhibitor. It is being investigated for the treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and inclusion body myositis.[L46742, L46747, L46752]
Investigational
Experimental
Matched Name: … 2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID …
Matched Iupac: … 2-(2,6-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid …
AR-42 has been used in trials studying the treatment of Meningioma, Acoustic Neuroma, Testicular Lymphoma, Intraocular Lymphoma, and Vestibular Schwannoma, among others.
Investigational
Matched Synonyms: … (S)-(+)-N-HYDROXY-4-(3-METHYL-2-PHENYL-BUTYRYLAMINO)-BENZAMIDE ... N-Hydroxy-4-(3-methyl-2-(S)phenyl-butyrylamino)benzamide ... N-hydroxy-4-[[(2S)-3-methyl-2-phenylbutanoyl]amino]benzamide …
Matched Iupac: … N-hydroxy-4-[(2S)-3-methyl-2-phenylbutanamido]benzamide …
VEGFR2-169 is under investigation in clinical trial NCT00655785 (Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)).
Investigational
Matched Iupac: … (2S,3S)-2-[(2S)-2-[(2S)-2-{2-[(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido ... carbamoylpropanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid ... ]-3-phenylpropanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanamido]acetamido}-3- …
Matched Description: … Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2) …
Investigational
Displaying drugs 5926 - 5950 of 11085 in total